NCT04949945

Brief Summary

The purpose of the study is to know the efficacy of Cognitive Behaviour Therapy on Positive Health Outcomes of Chronic Heart Failure Patients with Depression. It is a Randomized Control Trial (RCT) in which patients will be selected through purposive sampling techniques. Ages of patients will be 18-60 years. Data will be collected at outpatient department (OPD) of Ch.Pervaiz Elahi Institute of Cardiology Multan.Total measured sample size is 70 calculated by using G\*Power 3.1.9.4.Patients will be randomized into Interventional and Control group, with 1:1 allocation, 35 patients in each group by virtual randomization(www.randomization.com). Diagnosed patients of heart failure for 6 or more than 6 months duration, EF ≤ 40 % on Trans Thoracic Echocardiography, patients with NYHA Heart Failure class II and III, patients with "mild" to "severe" level of depression based on PHQ-9 .Patients with other Psychiatric Disorders except depression, any substance dependence, mentally retarded, having personality disorders, already have received any psychotherapy or any psychiatric medication will be excluded. Patients will be assessed for functional disability by WHODAS 2.0 and severity of Heart Failure will be assessed by a Cardiologist using NYHA Heart Failure classification. Patients in experimental group will receive treatment as usual (TAU) and culturally adapted Cognitive Behavior Therapy. Patients in control group will receive treatment as usual (TAU) by a Cardiologist . The aim of this experimental study is to study the efficacy of culturally adapted Cognitive Behavioral Therapy in patients with chronic heart failure with depression. To study the above-mentioned phenomenon, following hypotheses are formulated: Hypothesis 1: Patients receiving culturally adapted Cognitive-Behavioral Therapy will show reduction in their level of depression than patients not receiving intervention. Hypothesis 2: Patients will improve in NHYA heart failure class, by receiving CaCBT in experimental group as compared to control group. Hypothesis 3: Patients who will receive CaCBT will show less repeated Hospitalization in experimental group as compared to control group. Hypothesis 4: Patients in the intervention group will show betterment in the functional disability from pretest to post-test as compared to non- interventional group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2021

Completed
Last Updated

September 8, 2021

Status Verified

September 1, 2021

Enrollment Period

7 months

First QC Date

June 3, 2021

Last Update Submit

September 5, 2021

Conditions

Keywords

Chronic Heart FailureDepressionSelf Help Culturally Cognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (1)

  • change in scores of depression measured by patients' health questionnaire 9

    change in scores of depression will be measured by Patients' Health Questionnaire 9. The PHQ-9 total score ranges from 0 to 27 (scores of 0- 4 are classified as none,5-9 mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; 20-27 as severe depression )from baseline to 2 and half months of intervention in control and experimental group.

    change from baseline scores of depression at 2 and half months of intervention in experimental and control group.

Secondary Outcomes (3)

  • change in functional disability by world health organization disability assessment schedule II version.

    Change in functional disability scores by world health organization disability assessment schedule II version will be measured from baseline to 2 and half months of intervention in control and experimental group.

  • Change in New York Heart Association Classification of patients by a consultant cardiologist.

    Change in class of New York Heart Association Classification of patients at 2 and half months of intervention and will be measured by a consultant cardiologist on New York Heart Association Classification in experimental and control group.

  • Change in number of repeated hospitalization by patients' feedback.

    Change in experimental group's number of repeated hospitalization compared to control group's repeated number of hospitalization after 2 and half months of intervention.

Study Arms (2)

CHF patients who will receive guided self help culturally adapted cognitive behavioral therapy

EXPERIMENTAL

CHF(Chronic heart failure patients)(experimental group) will receive guided self help culturally adapted cognitive behavioral therapy.

Behavioral: Self Help Culturally Cognitive Behavioral Therapy

CHF patients will not receive guided self help culturally adapted cognitive behavioral therapy

NO INTERVENTION

CHF(Chronic heart failure patients) (control group) will not receive Self Help Culturally Cognitive Behavior Therapy.

Interventions

Experimental group (CHF patients)will be screened on PHQ9 questionnaire for depression after receiving guided self help culturally adapted cognitive therapy they will be reassessed for their depression,improvement in functional disability ,improvement in classification of NYHA,reduction in hospital admission as compare to control group.

CHF patients who will receive guided self help culturally adapted cognitive behavioral therapy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed heart failure patients for 6 and more than 6 months duration,
  • EF \< 40 % on Echocardiography ,
  • class II and III of NYHA heart failure,
  • "mild" to "severe" depression based on patients health questionnaire 9
  • who can understand, read, and write in Urdu will be included in study.

You may not qualify if:

  • any psychiatric disorders except depression,
  • substance dependence, mental retardation, personality disorders,
  • who have had received any psychotherapy or any psychiatric medication,
  • who are not willing to continue the sessions anymore, and the absence in more than two sessions will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chauhdary Pervaiz Ellahi Institute of Cardiology

Multan, Punjab Province, 60000, Pakistan

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student of PhD of Applied psychology

Study Record Dates

First Submitted

June 3, 2021

First Posted

July 2, 2021

Study Start

February 1, 2021

Primary Completion

September 10, 2021

Study Completion

November 29, 2021

Last Updated

September 8, 2021

Record last verified: 2021-09

Locations